Natixis Advisors LLC Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Natixis Advisors LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 526,809 shares of the medical equipment provider's stock after buying an additional 11,381 shares during the quarter. Natixis Advisors LLC owned 0.15% of Intuitive Surgical worth $258,805,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Creekmur Asset Management LLC grew its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. increased its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 35 shares during the period. LRI Investments LLC bought a new position in shares of Intuitive Surgical during the first quarter worth about $30,000. Finally, LGT Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 54 shares during the period. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, insider Jamie Samath sold 269 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of the firm's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 93.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 over the last ninety days. Insiders own 0.90% of the company's stock.

Intuitive Surgical Trading Down 1.9 %

Shares of ISRG traded down $10.19 during mid-day trading on Friday, reaching $527.61. 1,447,901 shares of the stock traded hands, compared to its average volume of 1,461,285. The company has a market cap of $187.92 billion, a price-to-earnings ratio of 84.82, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $295.02 and a 1 year high of $544.38. The firm has a fifty day moving average price of $499.29 and a 200 day moving average price of $457.28.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Ratings Changes

A number of analysts have commented on ISRG shares. Leerink Partners upped their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Royal Bank of Canada raised their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a research note on Friday, October 18th. Evercore ISI restated a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Redburn Atlantic upgraded shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Finally, Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.